SynapseBio uses Machine Learning
and EEG to Improve Detection and Treatment
of Dementia and Other Neurocognitive Disorders
SynapseBio is a venture backed Digital Health company founded within AlleyCorp focused on utilizing statistical and machine learning models to assess EEG and other biophysical data for the purpose of improving the detection and treatment of dementia and other neurocognitive disorders.
Current tools to diagnose, treat or predict dementia are
Advanced statistical analysis and machine learning technology unlocks valuable information hidden within EEG data, including
What How We Do
Over the past several years, SynapseBio has developed and refined a domain specific process and algorithm trained to clean and standardize EEG data and generate ML features which has demonstrated efficacy in advanced disease detection across multiple neurocognitive disorders